TerminatedNot Applicable

LSFG-SKIN, Laser Speckle Flowgraphy

Stopped: This study was stopped 3/2/18 as the company who supported the device went out of business and requested the device be returned. Only 1 control subject was tested, no analyzable data.

United States1 participantsStarted 2017-05-23

Plain-language summary

The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.

Who can participate

Age range

18 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Controls ●Healthy normal control subjects ages 18-90 Cardiology Subjects * Ages 18-90 * History of dysrhythmia, heart failure, cardiac ischemia, hypertension, peripheral vascular disease Dermatology Subjects * Ages 18-90 * History of inflammatory and cancerous lesions Endocrine Subjects * Ages 18-90 * History of diabetes, thyroid disease Neurology Subjects * Ages 18-90 * History of dementia, headaches, Parkinson's, light sensitivity, stroke, TIA, multiple sclerosis Psychiatry Subjects * Ages 18-90 * History of bipolar, schizophrenia, anxiety, depression Surgery Subjects * Ages 18-90 * History of skin wounds(trauma, chemotherapy, radiation), thermal burns, or plastic and reconstructive surgical procedures. Ophthalmology Subjects * Ages 18-90 * History of ocular disorders caused by hypo perfusion or inflammatory disorders Exclusion Criteria: Controls * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Cardiology Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma 3\. Dermatology Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Endocrine Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Neurology Subjects * Cataract o…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Imaging Blood Flow

Timeframe: One visit

Trial details

NCT IDNCT03660618

SponsorRandy Kardon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03-02

Results submitted2019-05-07

View on ClinicalTrials.gov More Hypertension trials

Who can participate

Age range

18 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.